Cisplatin demonstrates its anti-tumor properties by interfering with vital cellular functions. Similar to a molecular jigsaw piece, it intertwines with the genetic material, obstructing its regular performance. Moreover, cisplatin interrupts the operation of polymerase, a critical enzyme engaged in gene routines. By solidifying the gene-polymerase coupling, it inhibits the enzyme's capacity to execute its roles, halting the ordinary flow of genetic-related tasks. In summary, cisplatin produces turmoil in the cell's layout, restricting the tumor cell's capacity to duplicate and thrive.

• This drug will be given by your physician or nurse; please refrain from self administration.
• Avoid using it on your own; anticipate for instructions from your physician or nurse.
• Rely on your medical professional to dispense the drug; do not try self-administration.

• Epirubicin is associated with cardiotoxicity, which is a potential risk to the heart. This may manifest as myocardial damage, heart failure, or other cardiac issues. Patients with preexisting heart conditions or those who have received previous anthracycline chemotherapy may be at a higher risk Monitoring of cardiac function, including regular echocardiograms or MUGA scans, may be necessary during treatment.
• Epirubicin can suppress the bone marrow, leading to decreased production of blood cells. This may result in anemia, leukopenia, or thrombocytopenia Regular blood cell count monitoring is essential, and dose adjustments may be needed based on hematologic parameters.

• Treats various cancers effectively.
• It helps stop cancer growth.
• Reduces the risk of spreading.

• Nausea
• Low blood platelets
• Hair loss
• Absence of menstrual periods
• Fever
• Anemia (low number of red blood cells)
• Diarrhea,